Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

Osman Öcal; Kerstin Schütte; Christoph J. Zech; Christian Loewe; Otto Van Delden; Vincent Vandecaveye; Chris Verslype; Bernhard Gebauer; Christian Sengel; Irene Bargellini; Roberto Iezzi; Alexander Philipp; Thomas Berg; Heinz J. Klümpen; Julia Benckert; Maciej Pech; Antonio Gasbarrini; Holger Amthauer; Peter Bartenstein; Bruno Sangro; Peter Malfertheiner; Jens Ricke; Max Seidensticker

doi:10.1007/s00259-022-05920-8

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

Osman Öcal, Kerstin Schütte, Christoph J. Zech, Christian Loewe, Otto Van Delden, Vincent Vandecaveye, Chris Verslype, Bernhard Gebauer, Christian Sengel, Irene Bargellini, Roberto Iezzi, Alexander Philipp, Thomas Berg, Heinz J. Klümpen, Julia Benckert, Maciej Pech, Antonio Gasbarrini, Holger Amthauer, Peter Bartenstein, Bruno SangroPeter Malfertheiner, Jens Ricke, Max Seidensticker

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	4716-4726
Numero di pagine	11
Rivista	European Journal of Nuclear Medicine and Molecular Imaging
Volume	49
DOI	https://doi.org/10.1007/s00259-022-05920-8
Stato di pubblicazione	Pubblicato - 2022

Keywords

Hepatocellular carcinoma
Objective response
mRECIST
Sorafenib
Radioembolization

Accesso al documento

10.1007/s00259-022-05920-8

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Öcal, O., Schütte, K., Zech, C. J., Loewe, C., Van Delden, O., Vandecaveye, V., Verslype, C., Gebauer, B., Sengel, C., Bargellini, I., Iezzi, R., Philipp, A., Berg, T., Klümpen, H. J., Benckert, J., Pech, M., Gasbarrini, A., Amthauer, H., Bartenstein, P., ... Seidensticker, M. (2022). Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib. European Journal of Nuclear Medicine and Molecular Imaging, 49, 4716-4726. https://doi.org/10.1007/s00259-022-05920-8

@article{945d89839de945818de3ca6e27906162,

title = "Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib",

keywords = "Hepatocellular carcinoma, Objective response, mRECIST, Sorafenib, Radioembolization, Hepatocellular carcinoma, Objective response, mRECIST, Sorafenib, Radioembolization",

author = "Osman {\"O}cal and Kerstin Sch{\"u}tte and Zech, {Christoph J.} and Christian Loewe and {Van Delden}, Otto and Vincent Vandecaveye and Chris Verslype and Bernhard Gebauer and Christian Sengel and Irene Bargellini and Roberto Iezzi and Alexander Philipp and Thomas Berg and Kl{\"u}mpen, {Heinz J.} and Julia Benckert and Maciej Pech and Antonio Gasbarrini and Holger Amthauer and Peter Bartenstein and Bruno Sangro and Peter Malfertheiner and Jens Ricke and Max Seidensticker",

year = "2022",

doi = "10.1007/s00259-022-05920-8",

language = "English",

volume = "49",

pages = "4716--4726",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7089",

publisher = "Springer Verlag",

}

Öcal, O, Schütte, K, Zech, CJ, Loewe, C, Van Delden, O, Vandecaveye, V, Verslype, C, Gebauer, B, Sengel, C, Bargellini, I, Iezzi, R, Philipp, A, Berg, T, Klümpen, HJ, Benckert, J, Pech, M, Gasbarrini, A, Amthauer, H, Bartenstein, P, Sangro, B, Malfertheiner, P, Ricke, J & Seidensticker, M 2022, 'Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, pagg. 4716-4726. https://doi.org/10.1007/s00259-022-05920-8

TY - JOUR

T1 - Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

AU - Öcal, Osman

AU - Schütte, Kerstin

AU - Zech, Christoph J.

AU - Loewe, Christian

AU - Van Delden, Otto

AU - Vandecaveye, Vincent

AU - Verslype, Chris

AU - Gebauer, Bernhard

AU - Sengel, Christian

AU - Bargellini, Irene

AU - Iezzi, Roberto

AU - Philipp, Alexander

AU - Berg, Thomas

AU - Klümpen, Heinz J.

AU - Benckert, Julia

AU - Pech, Maciej

AU - Gasbarrini, Antonio

AU - Amthauer, Holger

AU - Bartenstein, Peter

AU - Sangro, Bruno

AU - Malfertheiner, Peter

AU - Ricke, Jens

AU - Seidensticker, Max

PY - 2022

Y1 - 2022

KW - Hepatocellular carcinoma

KW - Objective response

KW - mRECIST

KW - Sorafenib

KW - Radioembolization

KW - Hepatocellular carcinoma

KW - Objective response

KW - mRECIST

KW - Sorafenib

KW - Radioembolization

UR - http://hdl.handle.net/10807/226554

U2 - 10.1007/s00259-022-05920-8

DO - 10.1007/s00259-022-05920-8

M3 - Article

SN - 1619-7089

VL - 49

SP - 4716

EP - 4726

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -